These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11190353)

  • 1. Nosocomial pneumonia. Diagnostic and therapeutic considerations.
    Cunha BA
    Med Clin North Am; 2001 Jan; 85(1):79-114. PubMed ID: 11190353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias.
    Cunha BA
    Med Clin North Am; 1995 May; 79(3):581-97. PubMed ID: 7752730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
    Kim A; Kuti JL; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
    Chapman TM; Perry CM
    Am J Respir Med; 2003; 2(1):75-107. PubMed ID: 14720024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
    Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
    Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
    Sun HK; Kuti JL; Nicolau DP
    Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia. Diagnostic and therapeutic approach.
    Cunha BA
    Med Clin North Am; 2001 Jan; 85(1):43-77. PubMed ID: 11190352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
    Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial pneumonia in the ICU--year 2000 and beyond.
    Bowton DL
    Chest; 1999 Mar; 115(3 Suppl):28S-33S. PubMed ID: 10084457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
    Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
    J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choice of empirical antibiotic therapy for nosocomial pneumonia.
    Ramirez JA
    J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonresolving or slowly resolving pneumonia.
    Kuru T; Lynch JP
    Clin Chest Med; 1999 Sep; 20(3):623-51. PubMed ID: 10516909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
    Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
    Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP
    Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nonresolving and progressive pneumonia.
    Menéndez R; Perpiñá M; Torres A
    Semin Respir Infect; 2003 Jun; 18(2):103-11. PubMed ID: 12840791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial pneumonia in pediatric patients: practical problems and rational solutions.
    Zar HJ; Cotton MF
    Paediatr Drugs; 2002; 4(2):73-83. PubMed ID: 11888355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired pneumonia.
    Cassiere HA; Niederman MS
    Dis Mon; 1998 Nov; 44(11):613-75. PubMed ID: 9858958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.